Market Overview:
The global dihydroxyacetone (DHA) market is expected to grow at a CAGR of 6.5% during the forecast period from 2018 to 2030. The growth in the market can be attributed to factors such as rising demand for DHA in cosmetics and medical applications, and increasing awareness about the benefits of DHA among consumers.
 Industry Outlook.svg)
Product Definition:
A colorless ketone that is the simplest possible diol, and is used as a tanning agent.
More than or euqal to99%:
DHA is a major constituent of the brain, eye, and nervous system. It is an omega-3 fatty acid that plays important roles in brain development and functioning as well as vision acuity. DHA can also help reduce depression, anxiety attacks, and symptoms of dementia among other conditions. The global population is expected to reach 9 billion by 2050; with more people suffering from chronic diseases like diabetes & Cardiovascular Diseases (CVDs).
Dihydroxyacetone (DHA) is a chemical compound and an organic liquid. It has a pungent odor similar to nail polish remover. Dihydroxyacetone is usually found in two forms, namely, solid and colorless crystals or as a clear liquid with no color. The product can be manufactured by both the synthetic as well as natural methods.
Application Insights:
The cosmetics application segment led the global market and accounted for more than 35.0% share of the total revenue in 2017. The product is used as a skin-conditioning agent, which helps to maintain skin¢â‚¬â„¢s moisture barrier function and helps prevent dryness, irritation and sensitivity due to its anti-inflammatory & antioxidant properties. Furthermore, it is used as an ingredient in various hair care formulations such as shampoos, conditioners & lotions that help enhance hair growth by improving scalp conditions including dandruff control.
Dihydroxyacetone has wide applications in medical field due to its antibacterial property against different types of bacteria including Staphylococcus aureus (golden staph), Escherichia coli (garden ecoli) and Candida albicans (yeast infection).
Regional Analysis:
Asia Pacific is expected to be the largest and fastest-growing regional market over the forecast period. The growth of this region can be attributed to increasing product consumption in countries, such as China, Japan, South Korea, and India. In addition, rising demand for personal care products due to rapid urbanization in these countries will drive the global market further.
The Asia Pacific was followed by Europe that accounted for a revenue share of 22% in 2017 owing to high demand from end-use industries including cosmetics and medical among other applications. Increasing consumer spending on beauty products has been driving regional growth since last few years; however now it is poised for a U-shape or W-shape cycle with lower volume sales compared with its peak levels during 2012 - 2016 period (see Figure 1).
Growth Factors:
- Increasing demand for natural and organic personal care products.
- Rising awareness about the benefits of DHA among consumers.
- Growing popularity of sunless tanning products.
- Increasing number of salons offering sunless tanning services.
- Expansion of retail distribution channels for sunless tanning products
Scope Of The Report
Report Attributes
Report Details
Report Title
Dihydroxyacetone(DHA) Market Research Report
By Type
More than or euqal to99%, <99%
By Application
Cosmetics, Medical, Other
By Companies
Merck KGaA, Adina, Hubei Marvel-Bio Medicine, Changxing Pharmaceutical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
237
Number of Tables & Figures
166
Customization Available
Yes, the report can be customized as per your need.
Global Dihydroxyacetone(DHA) Market Report Segments:
The global Dihydroxyacetone(DHA) market is segmented on the basis of:
Types
More than or euqal to99%, <99%
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Cosmetics, Medical, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Merck KGaA
- Adina
- Hubei Marvel-Bio Medicine
- Changxing Pharmaceutical
 Market Overview.svg)
Highlights of The Dihydroxyacetone(DHA) Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- More than or euqal to99%
- <99%
- By Application:
- Cosmetics
- Medical
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Dihydroxyacetone(DHA) Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
 Market Statistics.svg)
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Dihydroxyacetone is a ketone body that is produced during the breakdown of fatty acids. It can be found in small amounts in some foods, such as liver and meat.
Some of the key players operating in the dihydroxyacetone(dha) market are Merck KGaA, Adina, Hubei Marvel-Bio Medicine, Changxing Pharmaceutical.
The dihydroxyacetone(dha) market is expected to grow at a compound annual growth rate of 6.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Dihydroxyacetone(DHA) Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Dihydroxyacetone(DHA) Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Dihydroxyacetone(DHA) Market - Supply Chain
4.5. Global Dihydroxyacetone(DHA) Market Forecast
4.5.1. Dihydroxyacetone(DHA) Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Dihydroxyacetone(DHA) Market Size (000 Units) and Y-o-Y Growth
4.5.3. Dihydroxyacetone(DHA) Market Absolute $ Opportunity
5. Global Dihydroxyacetone(DHA) Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Dihydroxyacetone(DHA) Market Size and Volume Forecast by Type
5.3.1. More than or euqal to99%
5.3.2. <99%
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Dihydroxyacetone(DHA) Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Dihydroxyacetone(DHA) Market Size and Volume Forecast by Application
6.3.1. Cosmetics
6.3.2. Medical
6.3.3. Other
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Dihydroxyacetone(DHA) Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Dihydroxyacetone(DHA) Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Dihydroxyacetone(DHA) Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Dihydroxyacetone(DHA) Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Dihydroxyacetone(DHA) Demand Share Forecast, 2019-2026
9. North America Dihydroxyacetone(DHA) Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Dihydroxyacetone(DHA) Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Dihydroxyacetone(DHA) Market Size and Volume Forecast by Application
9.4.1. Cosmetics
9.4.2. Medical
9.4.3. Other
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Dihydroxyacetone(DHA) Market Size and Volume Forecast by Type
9.7.1. More than or euqal to99%
9.7.2. <99%
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Dihydroxyacetone(DHA) Demand Share Forecast, 2019-2026
10. Latin America Dihydroxyacetone(DHA) Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Dihydroxyacetone(DHA) Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Dihydroxyacetone(DHA) Market Size and Volume Forecast by Application
10.4.1. Cosmetics
10.4.2. Medical
10.4.3. Other
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Dihydroxyacetone(DHA) Market Size and Volume Forecast by Type
10.7.1. More than or euqal to99%
10.7.2. <99%
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Dihydroxyacetone(DHA) Demand Share Forecast, 2019-2026
11. Europe Dihydroxyacetone(DHA) Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Dihydroxyacetone(DHA) Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Dihydroxyacetone(DHA) Market Size and Volume Forecast by Application
11.4.1. Cosmetics
11.4.2. Medical
11.4.3. Other
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Dihydroxyacetone(DHA) Market Size and Volume Forecast by Type
11.7.1. More than or euqal to99%
11.7.2. <99%
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Dihydroxyacetone(DHA) Demand Share, 2019-2026
12. Asia Pacific Dihydroxyacetone(DHA) Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Dihydroxyacetone(DHA) Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Dihydroxyacetone(DHA) Market Size and Volume Forecast by Application
12.4.1. Cosmetics
12.4.2. Medical
12.4.3. Other
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Dihydroxyacetone(DHA) Market Size and Volume Forecast by Type
12.7.1. More than or euqal to99%
12.7.2. <99%
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Dihydroxyacetone(DHA) Demand Share, 2019-2026
13. Middle East & Africa Dihydroxyacetone(DHA) Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Dihydroxyacetone(DHA) Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Dihydroxyacetone(DHA) Market Size and Volume Forecast by Application
13.4.1. Cosmetics
13.4.2. Medical
13.4.3. Other
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Dihydroxyacetone(DHA) Market Size and Volume Forecast by Type
13.7.1. More than or euqal to99%
13.7.2. <99%
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Dihydroxyacetone(DHA) Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Dihydroxyacetone(DHA) Market: Market Share Analysis
14.2. Dihydroxyacetone(DHA) Distributors and Customers
14.3. Dihydroxyacetone(DHA) Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Merck KGaA
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Adina
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Hubei Marvel-Bio Medicine
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Changxing Pharmaceutical
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. COMPANY5
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. COMPANY6
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. COMPANY7
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. COMPANY8
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
